Adrian Liew, MD
Dr. Adrian Liew is a Senior Consultant Nephrologist and the Director of The Kidney and Transplant Practice at Mount Elizabeth Novena Hospital in Singapore. He was the founding Chief of Nephrology at Tan Tock Seng Hospital’s Department of Renal Medicine and also a Senior Consultant with the Ministry of Health, where he was involved in various national initiatives including implementing the national HALT-CKD program that successfully reduced the national ESKD rate. In addition, he was an Associate Professor at Nanyang Technological University-Imperial College London’s Lee Kong Chian School of Medicine, where he oversaw the renal medicine curriculum and clinical examination.
In recognition of his expertise in nephrology, Dr. Liew was elected to Fellowship status of various international academic institutions including the Academy of Medicine Singapore, Royal College of Physicians of Edinburgh and the American Society of Nephrology. In 2020, he became the only Singaporean and Southeast Asian to receive the John Mayer Award from the International Society for Peritoneal Dialysis (ISPD), an award that honours individuals who have made significant contributions to the field of peritoneal dialysis.
Internationally, Dr. Liew is a member of the Executive Committee and an elected council member of the International Society of Nephrology (ISN), as well as the elected secretary and executive of ISPD. He chairs the ISN Oceania-Southeast Asia Regional Board, ISN Renal Disaster Preparedness Working Group and Dialysis Sub-group for the ISN Global Strategy for ESKD. He is involved in the development and publication of various international clinical practice guidelines, including being an appointed member of the KDIGO Guideline working groups for glomerular diseases and diabetes management in chronic kidney disease, chairing the Asian-Pacific Society of Nephrology clinical practice guideline on diabetic kidney disease, and a member of the ISPD recommendations on prescribing high-quality, goal-directed peritoneal dialysis. He is a Scientific Leader with George Clinical and is the national leader and global steering committee member for various multicentre clinical trials.